Eli Lilly and Company (NYSE:LLY) is one of the best long-term growth stocks to buy and hold forever. On September 23, the ...

In the past week, Eli Lilly received U.S. FDA approval for Inluriyo, an oral estrogen receptor antagonist for estrogen ...

Indianapolis-based Eli Lilly intends to build a biomanufacturing facility that would cost $6.5 billion to build and employ ...

Eli Lilly's massive investment in Houston is even larger than it initially proposed just four months ago when it applied for ...

Eli Lilly plans to build a $6.5 billion factory in Houston, with construction expected to be completed by 2030.

Eli Lilly's CEO reveals the behind-the-scenes factors that led the pharmaceutical giant to choose Houston for its massive new ...

Eli Lilly and Co. (NYSE: LLY) confirmed Sept. 23 that the Bayou City will be part of its domestic manufacturing push. David ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

Eli Lilly (LLY) stock is in focus as the company plans to invest $6.5B to build a new Houston plant for small molecule drugs, ...

The planned site, which will be used to manufacture the company’s first oral weight-loss drug, is expected to be operational ...

Pharma giant Eli Lilly confirmed plans for the plant in Houston where an oral GLP-1 weight loss drug could be made, creating ...

Eli Lilly and Company plans to invest $6.5 billion to build a manufacturing facility at Generation Park in Houston, Texas.